106 related articles for article (PubMed ID: 11410276)
1. Inactivation of the serpin alpha(2)-antiplasmin by stromelysin-1.
Lijnen HR; Van Hoef B; Collen D
Biochim Biophys Acta; 2001 Jun; 1547(2):206-13. PubMed ID: 11410276
[TBL] [Abstract][Full Text] [Related]
2. Matrix metalloproteinases and cellular fibrinolytic activity.
Lijnen HR
Biochemistry (Mosc); 2002 Jan; 67(1):92-8. PubMed ID: 11841344
[TBL] [Abstract][Full Text] [Related]
3. alpha 2-Antiplasmin Enschede: dysfunctional alpha 2-antiplasmin molecule associated with an autosomal recessive hemorrhagic disorder.
Kluft C; Nieuwenhuis HK; Rijken DC; Groeneveld E; Wijngaards G; van Berkel W; Dooijewaard G; Sixma JJ
J Clin Invest; 1987 Nov; 80(5):1391-400. PubMed ID: 2445779
[TBL] [Abstract][Full Text] [Related]
4. Characterization of stromelysin 1 (MMP-3), matrilysin (MMP-7), and membrane type 1 matrix metalloproteinase (MT1-MMP) derived fibrin(ogen) fragments D-dimer and D-like monomer: NH2-terminal sequences of late-stage digest fragments.
Bini A; Wu D; Schnuer J; Kudryk BJ
Biochemistry; 1999 Oct; 38(42):13928-36. PubMed ID: 10529239
[TBL] [Abstract][Full Text] [Related]
5. Alpha 2-antiplasmin Enschede is not an inhibitor, but a substrate, of plasmin.
Rijken DC; Groeneveld E; Kluft C; Nieuwenhuis HK
Biochem J; 1988 Oct; 255(2):609-15. PubMed ID: 2974279
[TBL] [Abstract][Full Text] [Related]
6. Fibrinolysis is amplified by converting alpha-antiplasmin from a plasmin inhibitor to a substrate.
Sazonova IY; Thomas BM; Gladysheva IP; Houng AK; Reed GL
J Thromb Haemost; 2007 Oct; 5(10):2087-94. PubMed ID: 17883703
[TBL] [Abstract][Full Text] [Related]
7. The mechanism of activation of plasminogen at the fibrin surface by tissue-type plasminogen activator in a plasma milieu in vitro. Role of alpha 2-antiplasmin.
Rouy D; Anglés-Cano E
Biochem J; 1990 Oct; 271(1):51-7. PubMed ID: 1699517
[TBL] [Abstract][Full Text] [Related]
8. Secondary-site binding of Glu-plasmin, Lys-plasmin and miniplasmin to fibrin.
Suenson E; Thorsen S
Biochem J; 1981 Sep; 197(3):619-28. PubMed ID: 6459779
[TBL] [Abstract][Full Text] [Related]
9. Inactivation of plasminogen activator inhibitor-1 by specific proteolysis with stromelysin-1 (MMP-3).
Lijnen HR; Arza B; Van Hoef B; Collen D; Declerck PJ
J Biol Chem; 2000 Dec; 275(48):37645-50. PubMed ID: 10967118
[TBL] [Abstract][Full Text] [Related]
10. Generation of an angiostatin-like fragment from plasminogen by stromelysin-1 (MMP-3).
Lijnen HR; Ugwu F; Bini A; Collen D
Biochemistry; 1998 Apr; 37(14):4699-702. PubMed ID: 9548733
[TBL] [Abstract][Full Text] [Related]
11. Dissociation of alpha 2-plasmin-inhibitor-plasmin complex and regeneration of plasmin activity by SDS treatment.
Yan D; Urano T; Takada Y; Takada A
Thromb Res; 1993 Mar; 69(6):491-9. PubMed ID: 8503118
[TBL] [Abstract][Full Text] [Related]
12. Plasminogen binding by alpha 2-antiplasmin and histidine-rich glycoprotein does not inhibit plasminogen activation at the surface of fibrin.
Angles-Cano E; Rouy D; Lijnen HR
Biochim Biophys Acta; 1992 Dec; 1156(1):34-42. PubMed ID: 1472536
[TBL] [Abstract][Full Text] [Related]
13. [Binding of alpha-2-antiplasmin with fibrinogen/fibrin and their fragments independent of factor XIII].
Zadorozhna MB; Hrynenko TV; Iusova OI; Volkov HL
Ukr Biokhim Zh (1999); 2004; 76(5):71-7. PubMed ID: 16100900
[TBL] [Abstract][Full Text] [Related]
14. [Inhibition of the process of Glu-plasminogen activation by tissue activator with fibrin, DDE-complex, and D-dimer using alpha-2-antiplasmin].
Hrynenko TV; Zadorozhna MB; Platonova TM; Volkov HL
Ukr Biokhim Zh (1999); 2005; 77(5):45-51. PubMed ID: 16846069
[TBL] [Abstract][Full Text] [Related]
15. Proteolytic cleavage of urokinase-type plasminogen activator by stromelysin-1 (MMP-3).
Ugwu F; Van Hoef B; Bini A; Collen D; Lijnen HR
Biochemistry; 1998 May; 37(20):7231-6. PubMed ID: 9585535
[TBL] [Abstract][Full Text] [Related]
16. Purification and partial characterisation of alpha(2)-antiplasmin and plasmin(ogen) from ostrich plasma.
Thomas AR; Naudé RJ; Oelofsen W; Naganuma T; Muramoto K
Comp Biochem Physiol B Biochem Mol Biol; 2001 Jul; 129(4):809-20. PubMed ID: 11435135
[TBL] [Abstract][Full Text] [Related]
17. Noncovalent interaction of alpha(2)-antiplasmin with fibrin(ogen): localization of alpha(2)-antiplasmin-binding sites.
Tsurupa G; Yakovlev S; McKee P; Medved L
Biochemistry; 2010 Sep; 49(35):7643-51. PubMed ID: 20687529
[TBL] [Abstract][Full Text] [Related]
18. Alpha 2-antiplasmin Enschede: alanine insertion and abolition of plasmin inhibitory activity.
Holmes WE; Lijnen HR; Nelles L; Kluft C; Nieuwenhuis HK; Rijken DC; Collen D
Science; 1987 Oct; 238(4824):209-11. PubMed ID: 2958938
[TBL] [Abstract][Full Text] [Related]
19. Contribution of conserved lysine residues in the alpha2-antiplasmin C terminus to plasmin binding and inhibition.
Lu BG; Sofian T; Law RH; Coughlin PB; Horvath AJ
J Biol Chem; 2011 Jul; 286(28):24544-52. PubMed ID: 21543325
[TBL] [Abstract][Full Text] [Related]
20. Identification of molecular forms of plasminogen and plasmin-inhibitor complexes in urokinase-activated human plasma.
Müllertz S; Thorsen S; Sottrup-Jensen L
Biochem J; 1984 Oct; 223(1):169-77. PubMed ID: 6208893
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
